ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · IEX Real-Time Price · USD
0.0761
-0.0059 (-7.20%)
At close: Jul 19, 2024, 4:00 PM
0.0765
+0.0004 (0.53%)
Pre-market: Jul 22, 2024, 7:48 AM EDT
Company Description
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound.
The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.
It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
ENDRA Life Sciences Inc.
| Country | United States |
| IPO Date | May 9, 2017 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 21 |
| CEO | Francois Michelon |
Contact Details
Address: 3600 Green Court, Suite 350 Ann Arbor, Michigan 48105 United States | |
| Phone | 734-335-0468 |
| Website | endrainc.com |
Stock Details
| Ticker Symbol | NDRA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001681682 |
| CUSIP Number | 29273B104 |
| ISIN Number | US29273B3024 |
| Employer ID | 26-0579295 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Francois Michelon | Chairman, President and Chief Executive Officer |
| Irina Pestrikova | Senior Director of Finance and Secretary |
| Michael Thornton Ph.D. | Chief Technology Officer |
| Dr. Jonathan Behr Ph.D. | Co-Founder |
| Steve Freeman | Human Resources Leader |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 17, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jul 17, 2024 | 8-K | Current Report |
| Jun 25, 2024 | ARS | Filing |
| Jun 25, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 25, 2024 | DEF 14A | Other definitive proxy statements |
| Jun 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Jun 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Jun 12, 2024 | PRE 14A | Other preliminary proxy statements |
| Jun 6, 2024 | 8-K | Current Report |
| Jun 5, 2024 | 424B3 | Prospectus |